Surrozen (SRZN) Competitors

Olema Pharmaceuticals (NASDAQ:OLMA) and Surrozen (NASDAQ:SRZN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

Do analysts recommend OLMA or SRZN?

Olema Pharmaceuticals presently has a consensus price target of $24.00, suggesting a potential upside of 328.57%. Surrozen has a consensus price target of $38.50, suggesting a potential upside of 240.68%. Given Olema Pharmaceuticals' higher probable upside, analysts plainly believe Olema Pharmaceuticals is more favorable than Surrozen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Olema Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
Surrozen	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has higher valuation and earnings, OLMA or SRZN?

Surrozen has higher revenue and earnings than Olema Pharmaceuticals. Olema Pharmaceuticals is trading at a lower price-to-earnings ratio than Surrozen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Olema Pharmaceuticals	N/A	N/A	-$129.47M	-$1.98	-2.83
Surrozen	$10.65M	9.09	-$63.56M	-$14.42	-0.78

Does the media prefer OLMA or SRZN?

In the previous week, Olema Pharmaceuticals had 1 more articles in the media than Surrozen. MarketBeat recorded 3 mentions for Olema Pharmaceuticals and 2 mentions for Surrozen. Surrozen's average media sentiment score of 1.84 beat Olema Pharmaceuticals' score of 1.08 indicating that Surrozen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Olema Pharmaceuticals	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Surrozen	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Is OLMA or SRZN more profitable?

Olema Pharmaceuticals has a net margin of 0.00% compared to Surrozen's net margin of -274.42%. Olema Pharmaceuticals' return on equity of -42.58% beat Surrozen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Olema Pharmaceuticals	N/A	-42.58%	-38.65%
Surrozen	-274.42%	-545.43%	-64.40%

Which has more volatility and risk, OLMA or SRZN?

Olema Pharmaceuticals has a beta of 1.92, indicating that its stock price is 92% more volatile than the S&P 500. Comparatively, Surrozen has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500.

Do institutionals & insiders hold more shares of OLMA or SRZN?

91.8% of Olema Pharmaceuticals shares are held by institutional investors. Comparatively, 66.6% of Surrozen shares are held by institutional investors. 16.4% of Olema Pharmaceuticals shares are held by insiders. Comparatively, 45.2% of Surrozen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Olema Pharmaceuticals beats Surrozen on 9 of the 15 factors compared between the two stocks.